|A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19|
DR Boulware, MF Pullen, AS Bangdiwala, KA Pastick, SM Lofgren, ...
New England Journal of Medicine, 2020
|Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial|
CP Skipper, KA Pastick, NW Engen, AS Bangdiwala, M Abassi, ...
Annals of internal medicine 173 (8), 623-631, 2020
|Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19)|
KA Pastick, EC Okafor, F Wang, SM Lofgren, CP Skipper, MR Nicol, ...
Open Forum Infectious Diseases 7 (4), ofaa130, 2020
|Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales)|
K Dukik, JF Muņoz, Y Jiang, P Feng, L Sigler, JB Stielow, J Freeke, ...
Mycoses 60 (5), 296-309, 2017
|Clinical characteristics, diagnosis, management, and outcomes of disseminated emmonsiosis: a retrospective case series|
IS Schwartz, NP Govender, C Corcoran, S Dlamini, H Prozesky, R Burton, ...
Clinical Infectious Diseases 61 (6), 1004-1012, 2015
|Emerging fungal infections: New patients, new patterns, and new pathogens|
DZP Friedman, IS Schwartz
Journal of Fungi 5 (3), 67, 2019
|50 Years of Emmonsia Disease in Humans: The Dramatic Emergence of a Cluster of Novel Fungal Pathogens|
IS Schwartz, C Kenyon, P Feng, NP Govender, K Dukik, L Sigler, Y Jiang, ...
PLoS pathogens 11 (11), e1005198, 2015
|Outbreak Detection: First reported case of multidrug-resistant Candida auris in Canada|
IS Schwartz, GW Hammond
Canada Communicable Disease Report 43 (7-8), 150, 2017
|Phylogeny, ecology and taxonomy of systemic pathogens and their relatives in Ajellomycetaceae (Onygenales): Blastomyces, Emergomyces, Emmonsia, Emmonsiellopsis|
Y Jiang, K Dukik, JF Muņoz, L Sigler, IS Schwartz, NP Govender, ...
Fungal Diversity 90 (1), 245-291, 2018
|Blastomyces helicus, a New Dimorphic Fungus Causing Fatal Pulmonary and Systemic Disease in Humans and Animals in Western Canada and the United States|
IS Schwartz, NP Wiederhold, KE Hanson, TF Patterson, L Sigler
Clinical Infectious Diseases 68 (2), 188-195, 2019
|In vitro antifungal susceptibility of yeast and mold phases of isolates of dimorphic fungal pathogen Emergomyces africanus (formerly Emmonsia sp.) from HIV-infected South …|
TG Maphanga, E Britz, TG Zulu, RS Mpembe, SD Naicker, IS Schwartz, ...
Journal of clinical microbiology 55 (6), 1812-1820, 2017
|Effects of sexual network connectivity and antimicrobial drug use on antimicrobial resistance in Neisseria gonorrhoeae|
CR Kenyon, IS Schwartz
Emerging infectious diseases 24 (7), 1195, 2018
|AIDS-related endemic mycoses in Western Cape, South Africa, and clinical mimics: a cross-sectional study of adults with advanced HIV and recent-onset, widespread skin lesions|
IS Schwartz, C Kenyon, R Lehloenya, S Claasens, Z Spengane, ...
Open forum infectious diseases 4 (4), ofx186, 2017
|Emergomyces canadensis, a dimorphic fungus causing fatal systemic human disease in North America|
IS Schwartz, S Sanche, NP Wiederhold, TF Patterson, L Sigler
Emerging infectious diseases 24 (4), 758, 2018
|High rates of influenza-associated invasive pulmonary aspergillosis may not be universal: a retrospective cohort study from Alberta, Canada|
IS Schwartz, DZP Friedman, L Zapernick, TC Dingle, N Lee, W Sligl, ...
Clinical Infectious Diseases, 2020
|The emerging threat of antifungal resistance in transplant infectious diseases|
IS Schwartz, TF Patterson
Current infectious disease reports 20 (3), 2, 2018
|HIV prevalence correlates with high-risk sexual behavior in Ethiopia's regions|
CR Kenyon, A Tsoumanis, IS Schwartz
PloS one 10 (10), e0140835, 2015
|Partner concurrency and HIV infection risk in South Africa|
CR Kenyon, A Tsoumanis, IS Schwartz, B Maughan-Brown
International Journal of Infectious Diseases 45, 81-87, 2016
|Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial|
SA Lother, M Abassi, A Agostinis, AS Bangdiwala, MP Cheng, G Drobot, ...
Canadian Journal of Anaesthesia, 1, 2020
|Safety of hydroxychloroquine among outpatient clinical trial participants for COVID-19|
SM Lofgren, MR Nicol, AS Bangdiwala, KA Pastick, EC Okafor, ...
Open forum infectious diseases 7 (11), ofaa500, 2020